Drug Declaration

FCC ID: Q639555

Cover Letter(s)

Download: PDF
FCCID_1272030

LETTER OF AcENCY March 18, 2010 TRaC Global 100 Frobisher Business Park Leigh Sinton Road Malvern Worcestershire WR14 1BX UK To Whom It May Concern: We certify that Iridium Communications Inc. is not subject to denial of federal benefits, that includes FCC benefits, pursuant to Section 5301 of the Anti—Drug Abuse ACT of 1988, U.S.C. 862. Further, no party, as defined in 47 CFR 1.2002(b), to the application, is subject to denial of federal benefits, that includes FCC benefits. Thank you for your attention to these matters. kh Sincerely, Donna Bethea Murphy VP, Regulatory Engineering Iridium Communications Inc. 6707 Democtacy Boulevard, Suite 300, Bethesda, Maryland, USA 20817 « t: +1.301.571.6200 « : +1.301.571.6250 TRL 51F047 issO2B . 8440 South River Parkway, Tempe, Arizona, USA 85284 « t: +1.480.752. 1100 » £: +1.480.752.1105 » toll free: +1.866.947.4348 2030 East ASU Circle, Tempe, Arizona, USA 85284 « t: +1.480.752.4400 * £: +1.480.752.4405


Document Created: 2019-10-08 18:40:22
Document Modified: 2019-10-08 18:40:22
© 2024 FCC.report
This site is not affiliated with or endorsed by the FCC